Table 2.
Anti-inflammatory properties of phytosterols
| Molecules | Origins | Experimental methods | Key findings | Refs. |
|---|---|---|---|---|
| β-sitosterol | Ranunculus sceleratus L |
MTT assay 5-lipoxygenase (5-LOX) activity Oxazolone-induced mouse ear oedema |
Reduced oedema (in vivo) No effect on arachidonate pathway enzymes implicated in the inflammatory process (in vitro) |
[63] |
| – | Purchased |
Human aortic endothelial cells (HAECs) Monocyte (U937 cells) Attachment in tumor necrosis factor-α (TNF-α)-stimulated HAECs MTT assay Cytokine quantitation: ELISA |
Inhibited intracellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) expression in TNF-α Inhibited U937 cell binding to TNF-α Attenuated nuclear factor-κB (NF-κB) p65 phosphorylation |
[90] |
| – | Nyctanthes arbortristis |
Doses: 5, 10, and 20 mg/kg, i.p Wistar rats Hind paw oedema |
Inhibited paw oedema | [110] |
| – | Trachelospermum jasminoides | Lipopolysaccharide (LPS)-stimulated RAW264.7 murine macrophages |
Inhibited the activities of interleukin-6 (IL-6) of stimulated macrophages Reduced TNF-α and IL-1β secretion |
[111] |
| – | Purchased |
2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in mice C57BL/6 mice Immunoblotting ELISA measurement |
Decreased myeloperoxidase (MPO) activity (in vivo) Attenuated NF-κB Inhibited inflammatory enzymes Inhibited pro-inflammatory cytokines |
[72] |
| – | Esenbeckialeiocarpa |
Carrageenan-induced inflammation in the mouse air pouch model Calcium uptake measurement MPO and adenosine-deaminase (ADA) activity quantification |
Increased calcium uptake in activated neutrophils Inhibited ADA and MPO activity Inhibited TNF-α and IL-1β levels |
[73] |
| – | Purchased |
Mice with colitis after being fed a high fat diet (HFD) Intestinal mouse macrophages stimulated with lipopolysaccharides (LPS) ELISA measurement Immune blot analysis |
Ameliorated HFD-induced colitis through inhibition of LPS binding to toll-like receptor 4 (TLR4) in the NF-κB pathway | [71] |
| – | Justicia gendarussa burm. F |
Carrageenan-induced rat paw oedema model Calculated the percentage inhibition of oedema |
Induced potent anti-inflammatory effect by secreting prostaglandin (69.43%), serotin and bradykinin (52.25%), and histamine (30.07%) | [62] |
| – | Purchased | 26 C57BL/6 J male mice were fed a high fat western-style diet (HFWSD) and subsequently developed colitis through the induction of dextran sulfate sodium (DSS) |
Reduced the severity of colitis Suppressed NF-κB activation Decreased colonic inflammation score Decreased COX-2 expression |
[69] |
| – | Oxalis corniculata |
Doses: 5, 10, and 20 mg/kg, i.p Rat paw oedema model |
After 120 min, the administration of a dosage of 20 mg/kg resulted in: The inhibition of rat paw edema, reducing it to a volume of 0.32 ± 0.06 mL |
[61] |
| – | Moringa oleifera |
Doses: 7.5 − 30 μM HaCaT cells (keratinocytes) J774A.1 cells (macrophages) |
Secretion of inflammatory factors (IL-1β, IL-6, TNF-α, and ROS) from both keratinocytes and macrophages was effectively suppressed Inhibited caspase-1 activation Partially inhibited NF-κB in macrophages |
[101] |
| – | Purchased |
Wistar male rats ELISA measurement RT-PCR analysis |
Inhibiting inflammatory reactions, particularly TNF-α | [112] |
| – | Purchased |
LPS-exposed BV2 murine microglial cells CCK-8 assay ELISA measurement RT-PCR analysis Western blot analysis |
Reduced inflammatory mediator [IL-6, COX-2, TNF-α, and inducible nitric oxide (iNOS)] expression Inhibited NF-κB, ERK, and p38 pathway activation |
[80] |
| – | Purchased |
Induction of arthritis via complete freund’s adjuvant Swiss Wistar rats Poly-arthritic index ELISA measurement qRT-PCR analysis |
Reduced paw edema and arthritic index Reduced cytokines Reduced the level of COX-2, prostaglandin E2 (PGE2), NF-κB, and vascular endothelial growth factor (VEGF) |
[64] |
| – | Purchased |
Dose: 1 mg/kg Puncture (CLP)-induced septic rats ELISA measurement RT-qPCR analysis |
Decreased cytokine levels | [97] |
| – | Not reported |
Dose: 150 mg/kg, p.o Female Wistar rats ELISA measurement |
Down-regulated IL-6 and TNF-α levels Up-regulated endothelial nitric oxide synthase (eNOS) level |
[85] |
| – | Purchased |
RAW264.7 cells were stimulated with LPS, while C57BL/6 J mice developed acute lung injury as a result of LPS induction ELISA measurement RT-PCR analysis Western blot analysis |
Suppressed the mRNA levels of IL-6, TNF-α, and IL-1β (in vitro) Inhibited the activation of TLR4/NF-κB pathway activation |
[108] |
| – | Purchased |
A zebrafish larvae (Danio rerio) model of inflammation Neutrophil migration assay |
Inhibited neutrophil migration to the lateral line Reduced inflammatory gene (myd88 and il-8) expressions |
[78] |
| Ergosterol | Sarcodon aspratus (Berk.) S. Ito |
Murine macrophages (RAW264.7) HT29 colorectal adenocarcinoma cells |
Inhibited TNF-α secretion Inhibited IL-1α/β expression Suppressed JNK, MAPK p38, and ERK phosphorylation |
[98] |
| – | Purchased |
LPS-induced inflammation in RAW264.7 macrophages MTT assay Flow cytometry analysis Western blotting analysis |
Down-regulated proteins associated with the NF-κB cascade Inhibited TNF-α production Inhibited COX-2 expression |
[99] |
| – | Cordyceps militaris | BV2 microglia cells | Reduced nitric oxide (NO) in LPS triggered BV2 cells | [87] |
| – | Scleroderma Polyrhizum Pers., |
Doses: 25 and 50 mg/kg LPS-induced acute lung injury |
Inhibited inflammatory cells Inhibited pro-inflammatory cytokines (TNF-α and IL-6) Inhibited NF-κB, COX-2, and iNOS activation |
[104] |
| – | Purchased |
Chronic obstructive pulmonary disease (in vivo) ELISA measurement Western Blot analysis |
Inhibited cytokines in lung and serum Inhibited expression of JAK3/STAT3/NF-κB pathway (in vivo) |
[95] |
| – | Ganoderma sinense | NO production in RAW264.7 macrophages |
Exhibited anti-inflammatory activities against NO production IC50 = 17.7–32.4 μM |
[86] |
| – | Purchased |
CS-induced chronic obstructive pulmonary disease (COPD) model (in vivo and in vitro) 6HBE cells and Balb/c mice ELISA measurement Western blot analysis NF-κB/p65 activity assay |
Inhibited CS-induced o inflammation by inhibiting NF-κB/p65 activation | [21] |
| – | Anvillea garcinii | 5-LOX inhibitory potential | Displayed moderate 5-LOX inhibitory activity (IC50 = 3.06 − 3.57 mM) | [107] |
| – | Purchased |
Diabetic nephropathy-induced inflammation (in vivo) ELISA measurement RT-PCR analysis Western blot analysis |
Decreased inflammatory cytokine (MCP-1, TNF-α, and IL-6) levels Decreased NF-κB signaling pathway |
[102] |
| – | Cryptoporus volvatus |
LLC-PK1 cells RT-PCR analysis Western blot analysis Immunofluorescence assay Flow cytometry assay |
Decreased the mRNA levels of cytokines (PKR, Mx1, IFN-β, IFN-α) | [92] |
| – | Sclerotinia Sclerotiorum | Croton oil-induced ear edema quantification of MPO enzyme |
Inhibited ear edema, via inhibition of COX pathway activity Inhibited neutrophil recruitment |
[77] |
| – | Purchased |
TNF-α-induced HT-22 hippocampal cell injury Western blot analysis RT-PCR analysis |
Attenuated TNF-α toxicity on HT-22 cells Induced the overexpression of the EGR-1 transcription factor |
[113] |
| – | Antrodia camphorata |
LPS-induced microglial activation and neuro-inflammatory reactions (in vivo and in vitro) BV2 and HMC3 microglial cells Male ICR mice Western blot analysis Immunohistochemistry RT-PCR analysis |
Inhibited protein kinase B (AKT), NF-κB, and mitogen-activated protein kinase (MAPK) signaling pathways (in vitro) Decreased the levels of NF-κB phosphorylation and cytokines (in vivo) |
[26] |
| Stigmasterol | Mondia whytei |
Doses: 7.5, 15, 30, and 100 mg/kg Dimethylbenzene-induced ear edema test Adult Swiss albino mice |
Inhibited ear edema Induced anti-inflammatory activity (50.34% at 30 mg/kg) |
[66] |
| – | Purchased |
Human umbilical vein endothelial cells MTT assay Western blot analysis RT-PCR analysis Immunohistochemistry |
Down-regulated TNF-α No effect on other cytokines (IL-6 and CXCL-8) |
[96] |
| – | Purchased | Colitis in 26 C57BL/6 J male mice fed a HFWSD |
Reduced the severity of colitis Suppressed NF-κB activation Decreased colonic inflammation score Decreased COX-2 expression |
[69] |
| – | Purchased | Irritant dermatitis |
Controlled inflammatory characteristics (neutrophilia and ear skin edema) Suppressed pro-inflammatory cytokine expression Reduced TNF-α serum levels |
[65] |
| – | Purchased |
Collagen-induced arthritis (CIA)-induced inflammation in rats ELISA measurement qPCR analysis |
Inhibited TNF-α/IL-6/IL-1β/iNOS/COX-2 expression Augmented anti-inflammatory cytokine IL-10 expression Down-regulated NF-kBp65/p38MAPK expression Inhibited p-IKB-α activation |
[22] |
| – | Purchased |
Peritonitis Paw edema |
Reduced paw edema Decreased leukocyte infiltration Prevented paw licking Presented anti-inflammatory effects |
[67] |
| – | Purchased |
IL-1β-induced inflammation in primary rat articular chondrocytes MTT assay qRT-PCR analysis Western blot analysis |
Reduced IL-6 and iNOS expression Stigmasterol + mesenchymal stem cells-condition medium (MSC-CM) normalized pro-inflammatory/pro-catabolic responses and inhibited NF-κB activation |
[23] |
| – | Petiveria alliacea |
Pro-inflammatory mediator release by egg albumin protein Molecular Docking Studies against TNF-α and COX-2 |
At 6.5 kcal/mol: Better binding energy against TNF-α At 9.7 kcal/mol: Identified as hit molecule against COX-2 enzyme |
[114] |
| – | Purchased |
APPswe/PS1dE9 mice Simulated BV2 cells with Aβ42 oligomers ELISA measurement CCK8 assay Flow cytometry assay Western blot analysis |
Reduced microglia activation Reduced pro-inflammatory cytokine levels Protected BV2 cells via AMPK/NLRP3 and AMPK/NF-κB signaling |
[24] |
| – | Not reported |
RAW264.7 macrophages Splenocytes MTT assay qRT-PCR analysis Western blot analysis ELISA measurement |
Increased IL-2 and IFN-γ levels in RAW264.7 cells Up-regulated NF-κB activation in RAW264.7 cells Increased TNF-α secretion levels in splenocytes |
[34] |
| Fucosterol | Undaria pinnatifida |
LPS-induced RAW264.7 macrophages Western blot analysis qRT-PCR analysis |
Inhibited iNOS, TNF-α, and IL-6 expression Suppressed p38 MAPK and NF-κB pathways |
[81] |
| – | Eisenia bicyclis |
LPS-induced RAW264.7 macrophages MTT assay |
Suppressed COX-2 and iNOS expression Suppressed NF-κB pathway |
[79] |
| – | Hizikia fusiformis |
Atopic dermatitis-like lesions (in vivo) Mouse macrophage cells RAW264.7 macrophages Rat basophilic leukemia RBL-2H3 cells ELISA measurement |
Decreased LPS-induced production of NO (in vitro) Decreased DNCB-stimulated serum immunoglobulin E (IgE) levels Inhibited TNF-α and IL-4 levels Increased IFN-γ secretion |
[88] |
| – | Purchased |
Acute lung injury (in vivo) Alveolar macrophages (in vitro) MTT assay ELISA measurement Western blot analysis |
Attenuated cytokine production (in vivo) Inhibited NF-κB activation and cytokine production (in vitro) |
[100] |
| – | Hizikia fusiformis | Hypoxia damages to keratinocytes (HaCaT) |
Demonstrated a dose-dependent suppression of inflammation Inhibited the expression of IL-1β, IL-6, and TNF-α in HaCaT cells Suppressed HIF1-α accumulation |
[103] |
| – | Purchased |
β-amyloid (Aβ)- and LPS-induced microglial cells ELISA measurement RT-PCR analysis |
Inhibited IL-1β, IL-6, TNF-α, PGE2, and NO production | [89] |
| – | Sargassum binderi |
Particulate matter (PM)-induced inflammation in A459 human lung epithelial cells Western blot analysis |
Suppressed COX-2 and PGE2 Inhibited TNF-α and IL-6 Suppressed MAPK and NF-κB pathways |
[93] |
| – | Padina boryana |
PM-induced inflammation in RAW264.7 macrophages MTT assay Western blot analysis qRT-PCR analysis |
Down-regulated dose-dependently the production of inflammatory mediators (PGE2, COX-2, and iNOS) and pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β) Suppressed NF-κB and MAPK pathways |
[52] |
| – | Sargassum horneri |
Human dermal fibroblast (HDF) Western blot analysis RT-PCR analysis |
Down-regulated inflammatory mediators Regulated Nrf2/HO-1 signaling Regulated NF-κB and MAPK signalling |
[25] |